Akèy › Obèsite › Indiana › Gary
Etid klinik pou Obèsite nan Gary, IN
3 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Gary (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Velocity Clinical Research - Valparaiso, Valparaiso · 17 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Valparaiso · 17 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Valparaiso · 17 mi lwen
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL31 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD25 etid
- Jacksonville, FL25 etid
Lòt etid nan Gary
- Kansè poumon5 etid
- Kansè Poumon ki pa ti selil4 etid
- Kansè ovè4 etid
- Leksemi mieloïd egi4 etid
- Ensifizyans kadyak4 etid
- Kansè Endomèt3 etid
- Adenokasinom Ezofajyen3 etid
- Sipwa3 etid
- Kansè nan tete3 etid
- Kansè vejik3 etid
- Fibrilasyon atriyal3 etid
- Karsinòm selil skuamèz tèt ak kou3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.